AMGN

Amgen (AMGN)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:AMGN
DataOraFonteTitoloSimboloCompagnia
19/10/200920:57Dow Jones News2nd UPDATE: FDA Delays Decision On Amgen Bone DrugBIT:AMGNAmgen Inc.
19/10/200917:17Dow Jones NewsUPDATE: FDA Delays Decision On Amgen Bone Drug For Added InfoBIT:AMGNAmgen Inc.
19/10/200915:55Dow Jones NewsFDA Seeks Added Info On Amgen Bone Drug, Delays DecisionBIT:AMGNAmgen Inc.
16/10/200920:55Dow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesBIT:AMGNAmgen Inc.
14/10/200920:44Dow Jones NewsAmgen's Bone Drug May Face Delays In FDA DecisionBIT:AMGNAmgen Inc.
12/10/200916:57Dow Jones NewsDrug Stocks Edge Higher; DepoMed SinksBIT:AMGNAmgen Inc.
01/10/200919:22Dow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketBIT:AMGNAmgen Inc.
23/09/200916:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesBIT:AMGNAmgen Inc.
23/09/200911:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerBIT:AMGNAmgen Inc.
22/09/200913:28Dow Jones NewsAmgen's Denosumab Aids Bones In Breast-Cancer PatientsBIT:AMGNAmgen Inc.
17/09/200922:04Dow Jones NewsAmgen Hiring Mobile Reps In Building Bone Drug Sales ForceBIT:AMGNAmgen Inc.
17/09/200915:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixBIT:AMGNAmgen Inc.
15/09/200923:52Dow Jones News2nd UPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugBIT:AMGNAmgen Inc.
15/09/200923:39Dow Jones NewsUPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugBIT:AMGNAmgen Inc.
15/09/200918:22Dow Jones NewsUS Court Won't Disturb Injunction Against Roche Anemia DrugBIT:AMGNAmgen Inc.
25/08/200923:46Dow Jones NewsAmgen: Aranesp Doesn't Show Significant Bad Effects In StudyBIT:AMGNAmgen Inc.
17/08/200915:40Dow Jones NewsEuropean Biosimilars Market May Hint At Limited US ThreatBIT:AMGNAmgen Inc.
14/08/200917:29Dow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedBIT:AMGNAmgen Inc.
14/08/200901:34Dow Jones News5th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentBIT:AMGNAmgen Inc.
14/08/200900:51Dow Jones News4th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentBIT:AMGNAmgen Inc.
14/08/200900:03Dow Jones News3rd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentBIT:AMGNAmgen Inc.
13/08/200923:13Dow Jones News2nd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentBIT:AMGNAmgen Inc.
13/08/200922:10Dow Jones NewsUPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentBIT:AMGNAmgen Inc.
13/08/200921:38Dow Jones NewsFDA Panel Backs Denosumab As Osteoporosis TreatmentBIT:AMGNAmgen Inc.
11/08/200918:56Dow Jones NewsFDA: Amgen Osteoporosis Drug Could Affect Immune SystemBIT:AMGNAmgen Inc.
07/08/200919:01Dow Jones NewsAmgen's Cancer News Promising, But Bone Drug Still The FocusBIT:AMGNAmgen Inc.
04/08/200921:43Dow Jones NewsUPDATE: FDA: Requires Stronger Warnings For TNF Blocker DrugsBIT:AMGNAmgen Inc.
04/08/200920:05Dow Jones NewsFDA: Requires Stronger Class Warnings For TNF Blocker DrugsBIT:AMGNAmgen Inc.
04/08/200918:13Dow Jones NewsAmgen's Positive Bone Drug Data Missed Some High ExpectationsBIT:AMGNAmgen Inc.
04/08/200900:01Dow Jones NewsAmgen Bone Drug Shows Promise In Phase 3 TrialBIT:AMGNAmgen Inc.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:AMGN
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network